Two Sigma Advisers
DYN icon

Two Sigma Advisers’s Dyne Therapeutics DYN Stock Holding History

Two Sigma Advisers’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76,100
Closed -$1.79M – 2435
2024
Q4 		$1.79M Buy
76,100
+15,400
+25% +$456K ﹤0.01% 1169
2024
Q3 		$2.18M Sell
60,700
-63,300
-51% -$2.52M 0.01% 1020
2024
Q2 		$4.38M Buy
124,000
+110,400
+812% +$3.21M 0.01% 819
2024
Q1 		$386K Sell
13,600
-4,400
-24% -$99.5K ﹤0.01% 1975
2023
Q4 		$239K Sell
18,000
-33,600
-65% -$328K ﹤0.01% 2178
2023
Q3 		$462K Sell
51,600
-109,300
-68% -$1.18M ﹤0.01% 1818
2023
Q2 		$1.81M Sell
160,900
-75,600
-32% -$892K ﹤0.01% 1257
2023
Q1 		$2.72M Buy
236,500
+129,200
+120% +$1.68M 0.01% 1106
2022
Q4 		$1.24M Buy
107,300
+67,300
+168% +$779K ﹤0.01% 1473
2022
Q3 		$508K Buy
40,000
+15,700
+65% +$180K ﹤0.01% 1835
2022
Q2 		$167K Sell
24,300
-24,200
-50% -$167K ﹤0.01% 2310
2022
Q1 		$468K Sell
48,500
-1,400
-3% -$11.9K ﹤0.01% 2019
2021
Q4 		$593K Buy
49,900
+22,500
+82% +$316K ﹤0.01% 1837
2021
Q3 		$445K Buy
27,400
+1,500
+6% +$26.6K ﹤0.01% 1974
2021
Q2 		$545K Sell
25,900
-10,400
-29% -$196K ﹤0.01% 1914
2021
Q1 		$564K Buy
36,300
+11,900
+49% +$230K ﹤0.01% 1961
2020
Q4 		$512K Buy
+24,400
New +$483K ﹤0.01% 1855

Other funds holding DYN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's DYN Position: Q1 2025 in Review

Two Sigma Advisers sold out of Dyne Therapeutics (DYN) in Q1 2025, closing a stake of 76,100 shares — an estimated $1.79M sold.

Two Sigma Advisers first reported a position in DYN in Q4 2020 and held it in 17 quarters. The position peaked at $4.38M in Q2 2024. 205 funds tracked by Wall St. Rank hold DYN as of Q1 2025.

  • Two Sigma Advisers reported no remaining Dyne Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 76,100 Dyne Therapeutics shares in Q1 2025, an estimated $1.79M.
  • Two Sigma Advisers first reported a position in Dyne Therapeutics in Q4 2020 and held it in 17 quarters.
  • Two Sigma Advisers's Dyne Therapeutics position peaked at $4.38M in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.